Skip to main content
    R

    Reinsurance Group of America (RGA)

    Official site

    FINANCIAL SERVICES • INSURANCE - REINSURANCE • NYSE

    $271.93
    -3.23 (-1.17%)

    Market Cap: $17.90B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Reinsurance Group of America (RGA) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Reinsurance Group of America (RGA) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Reinsurance Group of America reported EPS of $8.49, above the $6.98 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    60%(24/40)
    Avg Surprise
    +11.50%
    Streak
    4 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$7.28
    Range$6.54 - $8.39
    12 analysts
    Revenue Consensus
    $7.06B
    Range$6.64B - $7.60B
    7 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$7.32
    Range$6.62 - $8.23
    8 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$7.17+2.1%
    60d ago$7.16+2.2%
    30d ago$7.31+0.1%
    7d ago$7.29+0.4%
    Current$7.32
    Revenue Consensus
    $6.92B
    Range$6.78B - $7.01B
    3 analysts

    Next Report

    RGA has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.1% below the $7.75 reported for the quarter ended Dec 31, 2025.

    RGA Earnings Call

    The latest RGA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, RGA beat 24, missed 15 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $7.45B, up 21.9% from $6.11B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$8.49$6.98$6.66 - $7.23+21.63%Beat+82.2%104 up, 1 downNov 5, 2026$7.45B
    Jun 30, 2026$8.89$6.51$6.36 - $6.61+36.56%Beat+88.3%102 up, 5 downAug 6, 2026$6.54B
    Mar 31, 2026$6.97$6.01$5.18 - $6.31+15.97%Beat+23.1%101 up, 2 downMay 7, 2026$6.39B
    Dec 31, 2025$7.75$5.75$5.49 - $6.16+34.78%Beat+55.3%102 up, 2 downFeb 5, 2026$6.54B
    Sep 30, 2025$4.66$5.77$5.53 - $5.98-19.24%Miss-24.0%115 up, 3 downOct 30, 2025$6.11B
    Jun 30, 2025$4.72$5.55$5.36 - $5.88-14.96%Miss-13.9%104 up, 3 downJul 31, 2025$5.51B
    Mar 31, 2025$5.66$5.34$5.10 - $5.76+5.99%Beat-6.0%92 up, 6 downMay 1, 2025$5.18B
    Dec 31, 2024$4.99$5.26$5.03 - $5.59-5.13%Miss+5.5%116 up, 1 downFeb 6, 2025$5.16B
    Sep 30, 2024$6.13$5.34$4.94 - $5.96+14.79%Beat+10.1%134 up, 0 downOct 31, 2024$5.57B
    Jun 30, 2024$5.48$5.09$4.61 - $5.55+7.66%Beat+24.5%124 up, 0 downAug 1, 2024$4.81B
    Mar 31, 2024$6.02$4.57$4.25 - $4.70+31.73%Beat+16.7%114 up, 1 downMay 2, 2024$6.27B
    Dec 31, 2023$4.73$4.46$4.18 - $4.83+6.05%Beat+58.2%131 up, 0 downFeb 1, 2024$4.94B
    Sep 30, 2023$5.57$4.28$4.13 - $4.50+30.14%Beat+7.1%122 up, 1 downNov 2, 2023$5.08B
    Jun 30, 2023$4.40$4.14$3.91 - $4.40+6.28%Beat-23.9%134 up, 0 downAug 3, 2023$4.09B
    Mar 31, 2023$5.16$3.35$3.00 - $3.76+54.03%Beat+997.9%138 up, 0 downMay 4, 2023$4.20B
    Dec 31, 2022$2.99$3.73$3.01 - $4.33-19.84%MissN/A123 up, 0 downFeb 2, 2023$4.30B
    Sep 30, 2022$5.20$3.00$2.60 - $3.29+73.33%BeatN/A122 up, 1 downNov 3, 2022$4.00B
    Jun 30, 2022$5.78$2.76N/A+109.42%Beat+44.5%N/A3 up, 0 downAug 4, 2022$3.86B
    Mar 31, 2022$0.47-$0.48-$1.53 - $0.81+197.92%BeatN/A111 up, 0 downMay 5, 2022$3.88B
    Dec 31, 2021-$0.56$0.79-$0.35 - $1.75-170.89%Miss-147.1%11N/AFeb 3, 2022$4.36B
    Sep 30, 2021-$1.11$2.46$1.63 - $3.23-145.12%Miss-131.6%9N/ANov 4, 2021$4.00B
    Jun 30, 2021$4.00$1.96$1.33 - $2.64+104.08%Beat+194.1%10N/AAug 3, 2021$4.09B
    Mar 31, 2021-$1.24-$0.33-$1.00 - $0.41-275.76%Miss-187.9%10N/AMay 6, 2021$4.07B
    Dec 31, 2020$1.19$1.02$0.50 - $1.90+16.67%Beat-65.3%10N/AFeb 8, 2021$4.20B
    Sep 30, 2020$3.51$1.77$1.00 - $2.28+98.31%Beat-12.7%10N/ANov 5, 2020$3.53B
    Jun 30, 2020$1.36-$0.85-$1.81 - -$0.09+260.00%Beat-58.9%10N/AAug 4, 2020$3.56B
    Mar 31, 2020$1.41$2.37$2.05 - $2.68-40.51%Miss-46.0%10N/AMay 5, 2020$3.13B
    Dec 31, 2019$3.43$3.66$3.56 - $3.75-6.28%Miss-0.9%10N/AJan 28, 2020$3.74B
    Sep 30, 2019$4.02$3.50$3.34 - $3.62+14.86%Beat-0.2%10N/AOct 30, 2019$3.58B
    Jun 30, 2019$3.31$3.42$3.31 - $3.74-3.22%Miss+6.8%10N/AJul 29, 2019$3.42B
    Mar 31, 2019$2.61$2.62$1.91 - $2.80-0.38%Miss+62.1%10N/AApr 29, 2019$3.38B
    Dec 31, 2018$3.46$3.46$3.34 - $3.650.00%In line+33.1%10N/AJan 28, 2019$3.24B
    Sep 30, 2018$4.03$3.27$3.16 - $3.42+23.24%Beat+17.2%10N/AOct 25, 2018$3.19B
    Jun 30, 2018$3.10$3.11$3.06 - $3.30-0.32%Miss+5.1%9N/AJul 26, 2018$3.16B
    Mar 31, 2018$1.61$2.44$2.26 - $2.87-34.02%Miss-13.4%10N/AApr 26, 2018$3.14B
    Dec 31, 2017$2.60$2.84$2.80 - $2.93-8.45%Miss-1.1%9N/AJan 29, 2018$3.20B
    Sep 30, 2017$3.44$2.63$2.52 - $2.72+30.80%Beat+39.8%8N/AOct 26, 2017$3.11B
    Jun 30, 2017$2.95$2.48$2.33 - $2.55+18.95%Beat+5.4%9N/AJul 27, 2017$3.10B
    Mar 31, 2017$1.86$2.14N/A-13.08%Miss+0.5%N/AN/AApr 27, 2017$2.97B
    Dec 31, 2016$2.63$2.53N/A+3.95%Beat-7.4%N/AN/AJan 30, 2017$3.03B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $22.79, up 0.8% from the year before. It was $9.74 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$22.79+0.8%
    Dec 31, 2024$22.62+13.9%
    Dec 31, 2023$19.86+37.5%
    Dec 31, 2022$14.44+1224.8%
    Dec 31, 2021$1.09-85.4%
    Dec 31, 2020$7.47-44.1%
    Dec 31, 2019$13.37+9.6%
    Dec 31, 2018$12.20+12.4%
    Dec 31, 2017$10.85+11.4%
    Dec 31, 2016$9.74N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,200 words across 12 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,23012
    2026Q2Jun 30, 20265,62412
    2026Q1Mar 31, 20265,40111
    2025Q4Dec 31, 20256,55114
    2025Q3Sep 30, 20255,99913
    2025Q2Jun 30, 20258,07215
    2025Q1Mar 31, 20258,36917
    2024Q4Dec 31, 20248,51115

    2026Q3 Earnings Call

    Opening remarks

    Tony Cheng CEO Good morning, everyone, and thank you for joining us today. We appreciate your continued interest in RGA. I am pleased to share that we delivered excellent results this quarter, with strong performance across all regions. Investment performance was robust, and economic claims experience was favorable to expectations, demonstrating our success on both sides of the balance sheet. These results were another proof point on the importance of our strategy and core differentiators: deep biometric expertise, strong asset management capabilities, a global platform of local offices, a market-leading brand, and flexibility to partner across the industry. They also demonstrate our ability to generate attractive risk-adjusted returns across a range of market environments. With this strong foundation in place, our priorities moving forward remain clear: deliver attractive, sustainable returns, manage risk well, and deploy capital where we see the best long-term value. Before I turn to the results, let me highlight three items from the quarter and how they tie to our strategy. First, our pipeline for both in-force and flow business remains attractive. This quarter, the U.S. PRT and U.K. longevity markets picked up after a slow start to the year. We were active in both, completing several transactions, and we are encouraged by the outlook for the fourth quarter and into 2027. Beyond these two markets, our other business segments continued to benefit from attractive opportunities, building on our strong market presence. Second, a key element of our biometric risk expertise is the rigor of our assumption-setting process. This quarter, we completed our annual assumption review. This resulted in no net impact on consolidated pretax adjusted operating income. The completion of the review gives us added confidence in both our in-force business and the new business we are writing. Finally, third-party capital remains a core element of our capital management strategy. These structures provide an opportunity for third-party investors to participate in the returns of our business while generating incremental fee income over time and enhancing our flexibility to fund growth and return capital to shareholders. In the quarter, I'm very pleased that we showed the continued execution of this strategy with the full deployment of Ruby Re capital. Turning now to the regional results. In the Americas, the results for the quarter were driven by strong investment income, sound underwriting experience, and the continued favorable impact of in-force actions executed in prior periods. New business momentum continued, and we were particularly pleased with the completion of four pension risk transfer transactions totaling over $800 million in combined premium. The overall pipeline for the region is encouraging, and we are seeing a wide range of opportunities across the spectrum of underwriting, product development, and asset-intensive transactions with biometric risk.

    Frequently Asked Questions About RGA

    When is Reinsurance Group of America's next earnings date?

    Reinsurance Group of America's next earnings report is expected for Feb 3, 2027.

    Did RGA beat earnings estimates last quarter?

    Yes. Reinsurance Group of America reported EPS of $8.49 for the quarter ended Sep 30, 2026, above the $6.98 estimate, a 21.63% surprise.

    What EPS do analysts expect from RGA next quarter?

    The consensus EPS estimate for Reinsurance Group of America for the quarter ending Dec 31, 2026 is $7.28 from 12 analysts, with estimates from $6.54 to $8.39.

    How often does RGA beat earnings estimates?

    Reinsurance Group of America beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +9.45%.